Exploiting synthetic lethality is key to targeting untapped cancer lesions, and we are seeing some success, our Dr. Tim Yap said at #AACR26. There are three challenges in the clinic now: widening the therapeutic index, functional biomarker development and rational combinations. #EndCancer